OBJECTIVE: Synovitis is a prevalent feature in patients with knee osteoarthritis (OA) and meniscal tear and is associated with pain and cartilage damage. Patient-reported swelling is also prevalent in this population. The aim of this study was to investigate the cross-sectional association between patient-reported swelling and effusion-synovitis detected by magnetic resonance imaging (MRI) in patients with OA and meniscal tear. METHODS: We used baseline data from a multicenter, randomized controlled trial, Meniscal Tear in Osteoarthritis Research (METEOR). MRI-identified effusion-synovitis, a proxy for effusion and synovitis on noncontrast MRIs, was graded as none/small versus medium/large. Using MRI-identified effusion-synovitis as the gold standard, we assessed the sensitivity, specificity, and positive predictive value of patient self-reported swelling in the previous week (none, intermittent, constant) to detect effusion and synovitis. RESULTS: We analyzed data from 276 patients. Twenty-five percent of patients reported no swelling, 40% had intermittent swelling, and 36% had constant swelling. Fifty-two percent had MRI-identified medium/large-grade effusion-synovitis. As compared with MRI-identified effusion-synovitis, any patient-reported swelling (versus none) had a sensitivity of 84% (95% confidence interval [95% CI] 77-89), a specificity of 34% (95% CI 26-43), and a positive predictive value of 57% (95% CI 54-61). A history of constant swelling (versus none or intermittent) showed a sensitivity of 46% (95% CI 37-54), a specificity of 75% (95% CI 67-82), and a positive predictive value of 66% (95% CI 58-74). CONCLUSION: We found that the sensitivity and specificity of patient-reported swelling were modest when compared with effusion-synovitis detected by MRI. These data urge caution against using patient-reported swelling as a proxy of inflammation manifesting as effusion-synovitis.
RCT Entities:
OBJECTIVE:Synovitis is a prevalent feature in patients with knee osteoarthritis (OA) and meniscal tear and is associated with pain and cartilage damage. Patient-reported swelling is also prevalent in this population. The aim of this study was to investigate the cross-sectional association between patient-reported swelling and effusion-synovitis detected by magnetic resonance imaging (MRI) in patients with OA and meniscal tear. METHODS: We used baseline data from a multicenter, randomized controlled trial, Meniscal Tear in Osteoarthritis Research (METEOR). MRI-identified effusion-synovitis, a proxy for effusion and synovitis on noncontrast MRIs, was graded as none/small versus medium/large. Using MRI-identified effusion-synovitis as the gold standard, we assessed the sensitivity, specificity, and positive predictive value of patient self-reported swelling in the previous week (none, intermittent, constant) to detect effusion and synovitis. RESULTS: We analyzed data from 276 patients. Twenty-five percent of patients reported no swelling, 40% had intermittent swelling, and 36% had constant swelling. Fifty-two percent had MRI-identified medium/large-grade effusion-synovitis. As compared with MRI-identified effusion-synovitis, any patient-reported swelling (versus none) had a sensitivity of 84% (95% confidence interval [95% CI] 77-89), a specificity of 34% (95% CI 26-43), and a positive predictive value of 57% (95% CI 54-61). A history of constant swelling (versus none or intermittent) showed a sensitivity of 46% (95% CI 37-54), a specificity of 75% (95% CI 67-82), and a positive predictive value of 66% (95% CI 58-74). CONCLUSION: We found that the sensitivity and specificity of patient-reported swelling were modest when compared with effusion-synovitis detected by MRI. These data urge caution against using patient-reported swelling as a proxy of inflammation manifesting as effusion-synovitis.
Authors: Carla R Scanzello; Brian McKeon; Bryan H Swaim; Edward DiCarlo; Eva U Asomugha; Veero Kanda; Anjali Nair; David M Lee; John C Richmond; Jeffrey N Katz; Mary K Crow; Steven R Goldring Journal: Arthritis Rheum Date: 2011-02
Authors: K Baker; A Grainger; J Niu; M Clancy; A Guermazi; M Crema; L Hughes; J Buckwalter; A Wooley; M Nevitt; D T Felson Journal: Ann Rheum Dis Date: 2010-05-14 Impact factor: 19.103
Authors: Frank W Roemer; David T Felson; Tianzhong Yang; Jingbo Niu; Michel D Crema; Martin Englund; Michael C Nevitt; Yuqing Zhang; John A Lynch; George Y El Khoury; James Torner; Cora E Lewis; Ali Guermazi Journal: Semin Arthritis Rheum Date: 2012-12-25 Impact factor: 5.532
Authors: D T Felson; J Niu; T Neogi; J Goggins; M C Nevitt; F Roemer; J Torner; C E Lewis; A Guermazi Journal: Osteoarthritis Cartilage Date: 2015-09-30 Impact factor: 6.576
Authors: Timothy Bhattacharyya; Daniel Gale; Peter Dewire; Saara Totterman; M Elon Gale; Sara McLaughlin; Thomas A Einhorn; David T Felson Journal: J Bone Joint Surg Am Date: 2003-01 Impact factor: 5.284
Authors: Jeffrey N Katz; Robert H Brophy; Christine E Chaisson; Leigh de Chaves; Brian J Cole; Diane L Dahm; Laurel A Donnell-Fink; Ali Guermazi; Amanda K Haas; Morgan H Jones; Bruce A Levy; Lisa A Mandl; Scott D Martin; Robert G Marx; Anthony Miniaci; Matthew J Matava; Joseph Palmisano; Emily K Reinke; Brian E Richardson; Benjamin N Rome; Clare E Safran-Norton; Debra J Skoniecki; Daniel H Solomon; Matthew V Smith; Kurt P Spindler; Michael J Stuart; John Wright; Rick W Wright; Elena Losina Journal: N Engl J Med Date: 2013-03-18 Impact factor: 91.245
Authors: Jamie E Collins; Elena Losina; Michael C Nevitt; Frank W Roemer; Ali Guermazi; John A Lynch; Jeffrey N Katz; C Kent Kwoh; Virginia B Kraus; David J Hunter Journal: Arthritis Rheumatol Date: 2016-10 Impact factor: 10.995
Authors: Tuhina Neogi; Ali Guermazi; Frank Roemer; Michael C Nevitt; Joachim Scholz; Lars Arendt-Nielsen; Clifford Woolf; Jingbo Niu; Laurence A Bradley; Emily Quinn; Laura Frey Law Journal: Arthritis Rheumatol Date: 2016-03 Impact factor: 10.995